15198-52-4 Usage
Chemical structure
A unique spiro ring structure with a benzyl group attached to the isoquinoline ring and a piperidine ring connected to the 4' position.
Type of compound
A heterocyclic organic compound, specifically a spiro compound.
Aromatic character
The benzyl group attached to the spiro ring provides the molecule with its aromatic character.
Flexibility
The piperidine ring adds flexibility to the molecule, which may be beneficial for binding to biological targets.
Pharmaceutical potential
Due to its unique structure and potential interactions with biological systems, this compound may have potential as a pharmaceutical agent.
Hydrochloride salt
The compound is a hydrochloride salt, which may affect its solubility and stability in different environments.
Research and development
The compound is a subject of interest for further research and development, particularly in the field of pharmaceuticals.
Biological target interactions
The compound's potential for binding to biological targets may be due to its unique structure and the presence of the piperidine ring.
Check Digit Verification of cas no
The CAS Registry Mumber 15198-52-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,1,9 and 8 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 15198-52:
(7*1)+(6*5)+(5*1)+(4*9)+(3*8)+(2*5)+(1*2)=114
114 % 10 = 4
So 15198-52-4 is a valid CAS Registry Number.
15198-52-4Relevant articles and documents
NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
-
Paragraph 0253; 0254, (2019/05/16)
Provided are 2-(piperidin-1-yl)pyrimidin-4(3H)-ones or pharmaceutically acceptable salts thereof, each characterized by having a 1,8-diazaspiro[4.5]deca-3-ene, 1-oxa-8-azaspiro[4.5]deca-3-ene, 2,8-diazaspiro[4.5]deca-3-ene, 2-oxa-8-azaspiro[4.5]deca-3-ene, 2,9-diazaspiro[5.5]undeca-3-ene, 1-oxa-9-azaspiro[5.5]undeca-3-ene, 1,9-diazaspiro[5.5]undeca-4-ene, or 3,9-diazaspiro[5.5]undeca-1-ene structure represented by the following general formula (1):